Antimicrobial peptides and proteins in the CF airway.
Cole
Alexander M
AM
Department of Medicine, Will Rogers Institute Pulmonary Research Laboratory, UCLA School of Medicine, Los Angeles, CA, USA.
Ganz
Tomas
T
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D015153:Blotting, Western; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D002624:Chemistry, Clinical / Q000379:methods*; D002851:Chromatography, High Pressure Liquid; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000382:microbiology*; D006801:Humans; D008168:Lung / Q000382:microbiology; D008247:Lysosomes / Q000378:metabolism; D017817:Nasal Lavage Fluid / Q000382:microbiology; D010455:Peptides; D013234:Stem Cells
D000900:Anti-Bacterial Agents; D010455:Peptides